Contineum Therapeutics, Inc. (CTNM) Operating margin
Contineum Therapeutics, Inc. (CTNM) operating margin by fiscal year — reported operating income divided by reported revenue.
32.2%FY2023
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | 32.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice